By-election of one director of the board in 2022
shareholders' meeting
Date of events
2022/05/24
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/05/24
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):natural-person director
3.Title and name of the previous position holder:NA
4.Resume of the previous position holder:NA
5.Title and name of the new position holder:Lin, Yi-Fu
6.Resume of the new position holder:
1.Independent Director of Taishin holdings
2.Independent Director of Taishin Bank
3.Independent Director of Nanya Technology
4.Minister,Ministry of Economic Affairs
5.Cabinet member,Executive Yuan
6.Ambassador, Permanent Mission of the Seperate Customs territory of Taiwan,
Penhu, Kinmen and Matsu to the world trade organization
7.Consultant, Chinese National Association of Industry and Commerce
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):New appointment
8.Reason for the change:By-election of one director of the board
9.Number of shares held by the new position holder when elected:0
10.Original term (from __________ to __________):2021/08/18~2024/08/17
11.Effective date of the new appointment:2022/05/24
12.Turnover rate of directors of the same term:1/7
13.Turnover rate of independent directors of the same term:NA
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:NA
Attachments
Original Link
Original Document
Permalink
Disclaimer
Oneness Biotech Co Ltd. published this content on 24 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 May 2022 11:18:04 UTC.
ONENESS BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include health supplies, health food and healthy food. The Company is also involved in the development of new drugs for the treatment of wound healing in chronic diabetic foot ulcers, as well as the development of new anticancer drugs. The Company distributes its products in domestic market.